Acyclovir achieves a lower concentration in African HIV-seronegative, herpes simplex virus 2-seropositive women than in non-African populations.
about
Microbicides: still a long road to successDaily acyclovir to decrease herpes simplex virus type 2 (HSV-2) transmission from HSV-2/HIV-1 coinfected persons: a randomized controlled trial.Summary measures of adherence using pill counts in two HIV prevention trials: the need for standardisation in reportingSynergistic Effect of ZnO Nanoparticles and Carbon Nanotube and Polymeric Film on Electrochemical Oxidation of Acyclovir.
P2860
Acyclovir achieves a lower concentration in African HIV-seronegative, herpes simplex virus 2-seropositive women than in non-African populations.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Acyclovir achieves a lower con ...... an in non-African populations.
@ast
Acyclovir achieves a lower con ...... an in non-African populations.
@en
type
label
Acyclovir achieves a lower con ...... an in non-African populations.
@ast
Acyclovir achieves a lower con ...... an in non-African populations.
@en
prefLabel
Acyclovir achieves a lower con ...... an in non-African populations.
@ast
Acyclovir achieves a lower con ...... an in non-African populations.
@en
P2093
P2860
P50
P356
P1476
Acyclovir achieves a lower con ...... an in non-African populations.
@en
P2093
Craig W Hendrix
Ellen Wilcox
James P Hughes
Jared M Baeten
P2860
P304
P356
10.1128/AAC.06160-11
P407
P577
2012-02-13T00:00:00Z